Filtros de búsqueda

Lista de obras de Elaine Hylek

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

artículo científico publicado en 2017

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

artículo científico publicado en 2017

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary

artículo científico publicado en 2017

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

artículo científico publicado en 2017

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary

artículo científico publicado en 2017

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary

artículo científico publicado en 2017

A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

artículo científico publicado en 2017

A response to - There's madness in their methods

A risk model predicted major bleeding in older patients with atrial fibrillation receiving warfarin therapy

artículo científico publicado en 2007

Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation ⬇️

artículo científico publicado el 4 de marzo de 1998

Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012

artículo científico publicado en 2014

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

artículo científico publicado en 2004

Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study

artículo científico publicado en 2006

American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association

artículo científico publicado en 2011

Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial

artículo científico publicado en 2014

Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

artículo científico publicado en 2016

Anticoagulation therapy for atrial fibrillation

artículo científico

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

artículo científico publicado en 2003

Antithrombotic prophylaxis in elderly patients with atrial fibrillation

artículo científico publicado en 2009

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician

artículo científico publicado en 2008

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.

artículo científico

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale

artículo científico publicado en 2010

Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

artículo científico publicado en 2013

Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

artículo científico publicado en 2015

Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation

scientific article published on 03 July 2019

Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation

Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation

scientific article published on 30 January 2019

Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy

artículo científico publicado en 2018

Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation

artículo científico

Bleeding risk assessment and management in atrial fibrillation patients

article by Laurent Fauchier et al published 2011 in Thrombosis and Haemostasis

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

scientific article published on May 2011

Bleeding risk on warfarin among elderly patients with atrial fibrillation

artículo científico publicado en 2010

Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry)

artículo científico publicado en 2019

Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

artículo científico publicado en 2015

Brand name versus generic warfarin: a systematic review of the literature

artículo científico publicado en 2011

Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial

scientific article published on 30 April 2020

Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.

artículo científico publicado en 2017

Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis

artículo científico publicado en 2003

Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation

artículo científico publicado en 2018

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.

artículo científico publicado en 2016

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.

artículo científico publicado en 2016

Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial

artículo científico publicado en 2017

Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

artículo científico publicado en 2014

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

artículo científico

Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial

artículo científico publicado en 2015

Clopidogrel, genetics, and drug responsiveness

artículo científico publicado en 2009

Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry

Comparison of ischemic stroke outcomes and patient and hospital characteristics by race/ethnicity and socioeconomic status

artículo científico publicado en 2013

Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors

artículo científico publicado en 2003

Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options

article

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

artículo científico publicado en 2011

Death and disability from warfarin-associated intracranial and extracranial hemorrhages

artículo científico publicado en 2007

Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation

scientific article published on 07 January 2020

Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum

artículo científico publicado en 2008

Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry

artículo científico

Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort

artículo científico publicado en 2015

Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)

artículo científico publicado en 2020

Disparate stroke rates on warfarin among contemporaneous cohorts with atrial fibrillation: potential insights into risk from a comparative analysis of SPORTIF III versus SPORTIF V.

artículo científico publicado en 2008

Does preadmission anticoagulation therapy reduce stroke severity in patients with atrial fibrillation?

artículo científico publicado en 2007

Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

artículo científico publicado en 2014

Dual antiplatelet and oral anticoagulant therapy: increasing use and precautions for a hazardous combination

artículo científico publicado en 2008

Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation

artículo científico publicado en 2013

Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

artículo científico publicado en 2018

Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)

scientific article published on 12 July 2020

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation

scientific article published on 12 September 2018

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

artículo científico publicado en 2003

Effectiveness of warfarin among patients with cancer

artículo científico publicado en 2007

Effects of apixaban compared with warfarin as gain in event-free time - a novel assessment of the results of the ARISTOTLE trial

scientific article published on 07 November 2019

Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial

artículo científico publicado en 2017

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

artículo científico publicado en 2014

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial

artículo científico publicado en 2012

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation

artículo científico publicado en 2013

Epidemiology of subtherapeutic anticoagulation in the United States

artículo científico publicado en 2009

Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

scientific article published on 01 September 2020

Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

artículo científico publicado en 2003

Factors Associated with Large Improvements in Health-Related Quality of Life in Patients with Atrial Fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

scientific article published on 16 April 2020

Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).

artículo científico publicado en 2017

Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

artículo científico publicado en 2016

Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute

artículo científico publicado en 2012

Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratification

artículo científico publicado en 2011

Gaps in monitoring during oral anticoagulation: insights into care transitions, monitoring barriers, and medication nonadherence

artículo científico publicado en 2013

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study

artículo científico publicado en 2005

Genetic testing for warfarin dosing? Not yet ready for prime time

artículo científico publicado en 2008

Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force

artículo científico publicado en 2006

Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARI

artículo científico

High blood pressure while taking antithrombotic medication is associated with an increased risk of developing intracranial haemorrhage ⬇️

artículo científico publicado el 25 de agosto de 2010

High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

artículo científico publicado en 2013

High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin

artículo científico publicado en 2013

Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23-25, 2008, Sao Paulo, Brazil

artículo científico publicado en 2009

Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil

artículo científico publicado en 2011

Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil

artículo científico publicado en 2012

Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, Brazil

artículo científico publicado en 2013

History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

artículo científico publicado en 2016

How the doctor got gagged

artículo científico publicado el 1 de julio de 1992

Identifying major hemorrhage with automated data: results of the Veterans Affairs study to improve anticoagulation (VARIA).

artículo científico publicado en 2012

Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

artículo científico publicado en 2015

Impaired platelet nitric oxide response in patients with new onset atrial fibrillation

artículo científico publicado en 2014

Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)

artículo científico publicado en 2015

Incremental prognostic value of renal function for stroke prediction in atrial fibrillation

scientific article published on 25 July 2018

Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling

artículo científico publicado en 2016

Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial

scientific article published on 01 April 2019

International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin

scientific article published on 01 July 2019

Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

artículo científico publicado en 2014

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

article

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation

artículo científico publicado en 2007

Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures

artículo científico publicado en 2014

Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry

artículo científico

Methodological considerations for interpretation of rates of major haemorrhage in studies of anticoagulant therapy for atrial fibrillation

artículo científico publicado en 2007

Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry

artículo científico publicado en 2018

N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).

artículo científico publicado en 2013

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation

artículo científico publicado en 2016

Non-vitamin K antagonist oral anticoagulants: an appeal for consensus on terminology

artículo científico publicado en 2014

Nonadherence with INR monitoring and anticoagulant complications

artículo científico publicado en 2013

North American Thrombosis Forum, AF Action Initiative Consensus Document

artículo científico publicado en 2016

Obesity begets atrial fibrillation: a contemporary summary

artículo científico publicado en 2013

Oral anticoagulant therapy for patients with atrial fibrillation--an update

artículo científico publicado en 2008

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation

artículo científico publicado en 2017

Organizational characteristics of high- and low-performing anticoagulation clinics in the Veterans Health Administration

artículo científico publicado en 2012

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry

artículo científico publicado en 2014

Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation

artículo científico publicado en 2019

Outcomes and predictors of very stable INR control during chronic anticoagulation therapy.

artículo científico publicado en 2009

Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial

scientific article published on 22 November 2018

Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF.

artículo científico publicado en 2011

Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial

scientific article published on 21 November 2019

Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry

artículo científico publicado en 2015

Patterns of oral anticoagulation use with cardioversion in clinical practice

artículo científico publicado en 2020

Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation

artículo científico

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

artículo científico publicado en 2008

Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF

scientific article published on 01 September 2018

Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

artículo científico publicado en 2014

Platelet hyperaggregability in patients with atrial fibrillation. Evidence of a background proinflammatory milieu.

artículo científico publicado en 2015

Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation

artículo científico publicado en 2017

Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation

artículo científico publicado en 2018

Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry

artículo científico publicado en 2015

Reducing the risk for stroke in patients who have atrial fibrillation

artículo científico publicado en 2008

Reexamining the recommended follow-up interval after obtaining an in-range international normalized ratio value: results from the Veterans Affairs study to improve anticoagulation

artículo científico publicado en 2011

Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time

artículo científico publicado en 2017

Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".

artículo científico publicado en 2014

Risk of thromboembolism with short-term interruption of warfarin therapy

artículo científico publicado en 2008

Risk-adjusted percent time in therapeutic range as a quality indicator for outpatient oral anticoagulation: results of the Veterans Affairs Study to Improve Anticoagulation (VARIA).

artículo científico publicado en 2010

Risks and Benefits of Anticoagulation in Atrial Fibrillation

Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials

artículo científico publicado en 2020

Stability of International Normalized Ratios in Patients Taking Long-term Warfarin Therapy

artículo científico publicado en 2016

Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHADS-VASc Scores: Findings From the ORBIT-AF I and II Registries

article published in 2018

Stroke prevention in atrial fibrillation: Closing the gap

artículo científico publicado en 2018

Stroke prevention in atrial fibrillation: current status and near-future directions

artículo científico publicado en 2011

Stroke prevention in elderly patients with atrial fibrillation

artículo científico publicado en 2007

The "gender gap" in authorship of academic medical literature--a 35-year perspective

artículo científico publicado en 2006

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

artículo científico publicado en 2016

The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations

scientific article published on 31 December 2018

The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation

artículo científico publicado en 2015

The business case for quality improvement: oral anticoagulation for atrial fibrillation

artículo científico publicado en 2011

The need for new oral anticoagulants in clinical practice

artículo científico publicado en 2009

The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation

artículo científico publicado en 2007

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

artículo científico publicado en 2016

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

artículo científico publicado en 2004

The risk of hemorrhage among patients with warfarin-associated coagulopathy

artículo científico publicado en 2006

Therapeutic Potential of Oral Factor Xa Inhibitors ⬇️

artículo científico publicado el 23 de diciembre de 2010

Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT-AF.

artículo científico publicado en 2018

Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study

artículo científico publicado en 2008

Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation

artículo científico publicado en 2006

Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation).

artículo científico publicado en 2017

Trends in anticoagulation management across community-based practices in the United States: the Anticoagulation Consortium to Improve Outcomes Nationally (ACTION) study

artículo científico publicado en 2003

Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease

artículo científico publicado en 2016

Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry

artículo científico publicado en 2013

Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation

artículo científico publicado en 2018

Venous thromboembolism after joint replacement in older male veterans with comorbidity

artículo científico publicado en 2013

Vitamin K antagonists and time in the therapeutic range: implications, challenges, and strategies for improvement ⬇️

artículo científico publicado el 1 de abril de 2013

Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility

artículo científico publicado en 2011

Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population

artículo científico publicado en 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda